Biogen (BIIB) option implied volatility low into discontinuing two Alzheimer's trials

March 21, 2019 7:55 AM

Biogen (NASDAQ: BIIB) March weekly and April call option implied volatility is at 27 compared to its 52-week range of 21 to 45 into discontinuing two Alzheimer's trials.

Categories

Options

Next Articles